The history of demergers shows the two new Webjet companies have more of a chance of creating shareholder value than if ...

Clinical-stage stem cell and regenerative medicine firm Cynata has four trials underway, three ending between late this year ...

Fortescue (ASX:FMG) surged by nearly 5% as iron ore prices continued to rise on the China news, hitting US$100.30 per tonne.

The rise and fall of Novo Resources is a cautionary tale about over-promotion, but its Pilbara gold prospects could yet yield ...

Supply cuts have seen sentiment lift for lithium miners this month, but chemical prices remain tame in Chinese market.

A little Chinese stimulus goes a long way for local Resources, sparking a 9.5pc surge to keep the market moving forward for ...

US rate cuts spark new gold highs up to US$2670/oz and De Grey hits nine-month high after baulking at Agnico takeover offer.

Social media has torn apart Coles and Woolworths' ESG reputations this week, with the duopoly accused of misleading pricing ...

Good morning, and Happy Friday! Here’s everything you need to know, and some things you don't, before the ASX opens today.

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes ...

Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) announced today it is undertaking a $20 million ...

It may be made of paper, but China's biggest stimulus reports in months have sent ASX mining stocks to the moon.